Novel Kefir Exopolysaccharides (KEPS) Mitigate Lipopolysaccharide (LPS)-Induced Systemic Inflammation in Luciferase Transgenic Mice through Inhibition of the NF-κB Pathway.
Antioxidants (Basel)
; 12(9)2023 Sep 05.
Article
in En
| MEDLINE
| ID: mdl-37760027
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Antioxidants (Basel)
Year:
2023
Document type:
Article